A citation-based method for searching scientific literature

Stefanie Engert, Barbara Wappenschmidt, Beate Betz, Karin Kast, Michael Kutsche, Heide Hellebrand, Timm O Goecke, Marion Kiechle, Dieter Niederacher, Rita K Schmutzler, Alfons Meindl. Hum Mutat 2008
Times Cited: 69







List of co-cited articles
441 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.
Marco Montagna, Maurizia Dalla Palma, Chiara Menin, Simona Agata, Arcangela De Nicolo, Luigi Chieco-Bianchi, Emma D'Andrea. Hum Mol Genet 2003
150
39


Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
Frans B L Hogervorst, Petra M Nederlof, Johan J P Gille, Cathal J McElgunn, Maartje Grippeling, Roelof Pruntel, Rein Regnerus, Tibor van Welsem, Resie van Spaendonk, Fred H Menko,[...]. Cancer Res 2003
255
33

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
435
31

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
28

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Thomas v O Hansen, Lars Jønson, Anders Albrechtsen, Mette K Andersen, Bent Ejlertsen, Finn C Nielsen. Breast Cancer Res Treat 2009
49
38


Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Sabine Preisler-Adams, Ines Schönbuchner, Britta Fiebig, Brigitte Welling, Bernd Dworniczak, Bernhard H F Weber. Cancer Genet Cytogenet 2006
43
39

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997
348
24

Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer.
Miguel de la Hoya, Sara Gutiérrez-Enríquez, Eladio Velasco, Ana Osorio, Ana Sanchez de Abajo, Ana Vega, Raquel Salazar, Eva Esteban, Gemma Llort, Rogelio Gonzalez-Sarmiento,[...]. Clin Chem 2006
55
29

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
21

High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
Petra Vasickova, Eva Machackova, Miroslava Lukesova, Jiri Damborsky, Ondrej Horky, Hana Pavlu, Jitka Kuklova, Veronika Kosinova, Marie Navratilova, Lenka Foretova. BMC Med Genet 2007
42
35

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
Jan P Schouten, Cathal J McElgunn, Raymond Waaijer, Danny Zwijnenburg, Filip Diepvens, Gerard Pals. Nucleic Acids Res 2002
21

Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.
Nadine Puget, Sophie Gad, Laure Perrin-Vidoz, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, Gilbert M Lenoir, Sylvie Mazoyer. Am J Hum Genet 2002
75
21

Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families.
Carolin Hartmann, Anika L John, Rüdiger Klaes, Wera Hofmann, Rainer Bielen, Rolf Koehler, Bart Janssen, Claus R Bartram, Norbert Arnold, Johannes Zschocke. Hum Mutat 2004
61
24

Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.
Simona Agata, Alessandra Viel, Lara Della Puppa, Laura Cortesi, Giusi Fersini, Monia Callegaro, Maurizia Dalla Palma, Riccardo Dolcetti, Massimo Federico, Salvatore Venuta,[...]. Genes Chromosomes Cancer 2006
45
31

Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, M C King. Genome Res 1996
222
20

BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Magdalena Ratajska, Izabela Brozek, Elzbieta Senkus-Konefka, Jacek Jassem, Magdalena Stepnowska, Grazia Palomba, Marina Pisano, Milena Casula, Giuseppe Palmieri, Ake Borg,[...]. Oncol Rep 2008
50
26

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer.
Y K Lim, P T C Lau, A B Ali, S C Lee, J E-L Wong, T C Putti, J-H Sng. Clin Genet 2007
43
27

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.
Mads Thomassen, Anne-Marie Gerdes, Dorthe Cruger, Peter K A Jensen, Torben A Kruse. Cancer Genet Cytogenet 2006
40
27


Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Sarai Palanca Suela, Eva Esteban Cardeñosa, Eva Barragán González, Silvestre Oltra Soler, Inma de Juan Jiménez, Isabel Chirivella González, Angel Segura Huerta, Carmen Guillén Ponce, Eduardo Martínez de Dueñas, Pascual Bolufer Gilabert. Breast Cancer Res Treat 2008
15
73

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ivana Ticha, Zdenek Kleibl, Jana Stribrna, Jaroslav Kotlas, Martina Zimovjanova, Martin Mateju, Michal Zikan, Petr Pohlreich. Breast Cancer Res Treat 2010
32
34

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families.
Sophie Gad, Virginie Caux-Moncoutier, Sabine Pagès-Berhouet, Marion Gauthier-Villars, Isabelle Coupier, Pascal Pujol, Marc Frénay, Brigitte Gilbert, Christine Maugard, Yves-Jean Bignon,[...]. Oncogene 2002
76
14

Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
Katri Pylkäs, Hannele Erkko, Jenni Nikkilä, Szilvia Sólyom, Robert Winqvist. BMC Cancer 2008
34
29

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.
Anne-Marie Moisan, Jessyka Fortin, Martine Dumont, Carolle Samson, Paul Bessette, Jocelyne Chiquette, Rachel Laframboise, Jean Lépine, Bernard Lespérance, Roxane Pichette,[...]. Genet Test 2006
42
23

Deletion of exons 1a-2 of BRCA1: a rather frequent pathogenic abnormality.
Ans M W van den Ouweland, Winand N M Dinjens, Lambert C J Dorssers, Monique M van Veghel-Plandsoen, Hennie T Brüggenwirth, Caroline J Withagen-Hermans, Johanna Margriet Collée, Simon A Joosse, Joan N R Terlouw-Kromosoeto, Petra M Nederlof. Genet Test Mol Biomarkers 2009
16
62

Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes.
Jesús del Valle, Lídia Feliubadaló, Marga Nadal, Alex Teulé, Rosa Miró, Raquel Cuesta, Eva Tornero, Mireia Menéndez, Esther Darder, Joan Brunet,[...]. Breast Cancer Res Treat 2010
28
35

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
Amelia Buffone, Carlo Capalbo, Enrico Ricevuto, Tina Sidoni, Laura Ottini, Mario Falchetti, Enrico Cortesi, Paolo Marchetti, Giovanni Scambia, Silverio Tomao,[...]. Breast Cancer Res Treat 2007
24
37

Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Sophia Armaou, Irene Konstantopoulou, Theodore Anagnostopoulos, Evangelia Razis, Ioannis Boukovinas, Nikolaos Xenidis, George Fountzilas, Drakoulis Yannoukakos. Eur J Cancer 2007
42
21

Significant contribution of germline BRCA2 rearrangements in male breast cancer families.
Isabelle Tournier, Brigitte Bressac-de Paillerets, Hagay Sobol, Dominique Stoppa-Lyonnet, Rosette Lidereau, Michel Barrois, Sylvie Mazoyer, Florence Coulet, Agnès Hardouin, Agnès Chompret,[...]. Cancer Res 2004
80
13

The contribution of germline rearrangements to the spectrum of BRCA2 mutations.
F Casilli, I Tournier, O M Sinilnikova, F Coulet, F Soubrier, C Houdayer, A Hardouin, P Berthet, H Sobol, V Bourdon,[...]. J Med Genet 2006
47
17

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
Maurizia Dalla Palma, Susan M Domchek, Jill Stopfer, Julie Erlichman, Jill D Siegfried, Jessica Tigges-Cardwell, Bernard A Mason, Timothy R Rebbeck, Katherine L Nathanson. Cancer Res 2008
76
11

The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.
Ana Peixoto, Catarina Santos, Patrícia Rocha, Manuela Pinheiro, Sofia Príncipe, Deolinda Pereira, Helena Rodrigues, Fernando Castro, Joaquim Abreu, Leonor Gusmão,[...]. Breast Cancer Res Treat 2009
43
18


Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson,[...]. Cancer Epidemiol Biomarkers Prev 2007
74
10

Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.
J Swensen, M Hoffman, M H Skolnick, S L Neuhausen. Hum Mol Genet 1997
108
10


Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.
N Puget, D Stoppa-Lyonnet, O M Sinilnikova, S Pagès, H T Lynch, G M Lenoir, S Mazoyer. Cancer Res 1999
151
10


A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
N Puget, D Torchard, O M Serova-Sinilnikova, H T Lynch, J Feunteun, G M Lenoir, S Mazoyer. Cancer Res 1997
147
10

Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
Patrícia M Machado, Rita D Brandão, Branca M Cavaco, Joana Eugénio, Sandra Bento, Mónica Nave, Paula Rodrigues, Aires Fernandes, Fátima Vaz. J Clin Oncol 2007
74
10

Genomic rearrangements in BRCA1 and BRCA2: A literature review.
Ingrid Petroni Ewald, Patricia Lisboa Izetti Ribeiro, Edenir Inêz Palmero, Silvia Liliana Cossio, Roberto Giugliani, Patricia Ashton-Prolla. Genet Mol Biol 2009
61
11


De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes.
Erik Teugels, Sylvia De Brakeleer, Guido Goelen, Willy Lissens, Erica Sermijn, Jacques De Grève. Hum Mutat 2005
60
10

Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
Sara Gutiérrez-Enríquez, Miguel de la Hoya, Cristina Martínez-Bouzas, Ana Sanchez de Abajo, Teresa Ramón y Cajal, Gemma Llort, Ignacio Blanco, Elena Beristain, Eduardo Díaz-Rubio, Carmen Alonso,[...]. Breast Cancer Res Treat 2007
37
16

Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
M Montagna, M Santacatterina, A Torri, C Menin, D Zullato, L Chieco-Bianchi, E D'Andrea. Oncogene 1999
71
8

An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?
N Puget, O M Sinilnikova, D Stoppa-Lyonnet, C Audoynaud, S Pagès, H T Lynch, D Goldgar, G M Lenoir, S Mazoyer. Am J Hum Genet 1999
114
8

High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability.
S Veschi, G Aceto, A P Scioletti, V Gatta, G Palka, A Cama, R Mariani-Costantini, P Battista, V Calò, F Barbera,[...]. Ann Oncol 2007
15
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.